3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
1
Pituitary ACTH Hypersecretion
1
Peritoneal Neoplasms
1
Ovarian Neoplasms
1
Ovarian Diseases
1
Neoplasms by Site
1
Neoplasms
1
Hypertension
1
Genital Neoplasms, Female
1
Fallopian Tube Neoplasms
1
Fallopian Tube Diseases
1
Endometrial Neoplasms
1
Diabetes Mellitus, Type 2
1
Cushing Syndrome
1
Carcinoma, Pancreatic Ductal
1
Adrenocortical Carcinoma
1
Adrenal Cortex Neoplasms
1
Adenocarcinoma
1
ACTH Syndrome, Ectopic
1
Interventions
pembrolizumab
44
Carboplatin
35
Paclitaxel
27
Specimen Handling
18
Cyclophosphamide
16
Capecitabine
16
Magnetic Resonance Spectroscopy
14
sacituzumab govitecan
13
Gemcitabine
13
Taxes
12
Biopsy
12
130-nm albumin-bound paclitaxel
11
Albumin-Bound Paclitaxel
9
Doxorubicin
8
olaparib
7
Nivolumab
7
fludarabine
6
Cisplatin
6
eribulin
5
atezolizumab
5
Radiotherapy
5
Docetaxel
5
durvalumab
4
Fulvestrant
4
Epirubicin
4
Bevacizumab
4
veliparib
3
famitinib
3
abemaciclib
3
Vinorelbine
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Triple Negative Breast Neoplasms
×
relacorilant
×
90 days
×
Clear all
No trials found.